Azithromycin fails to Improve Outcomes in Preterm Infants at Risk of chronic lung disease of prematurity: Lancet
Researchers have found that prophylactic azithromycin does not improve survival rates or reduce the incidence of chronic lung disease of prematurity (CLD) in preterm infants born at less than 30 weeks’ gestation, according to the results of the AZTEC trial …